 CytoSorbents Corporation NASDAQ: CTSO has entered into separate agreements with InvoSurg Inc. and Surgical Partners to commercialize CytoSorb under its FDA Emergency Use Authorization EUA in adult, critically-ill, COVID-19 patients with imminent or confirmed respiratory failure. Covering 15 states, Surgical Partners and InvoSurg will work with CytoSorbents to sell and distribute CytoSorb in Florida, and the Northeast and Mid-Atlantic United States, from Maine to Virginia, respectively. 